PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm

Virus-like particles: Versatile platforms

Vaccination represents, together with the supply of fresh water, the most efficient tool to prevent infectious diseases in human. Vaccines` power is undeniable, ever since the worldwide eradication of smallpox in the 1970s. Besides their high efficacy, the conventional dead or live-attenuated vaccines suffer substantial drawbacks, especially regarding their safety. David Wetzel at ARTES Biotechnology GmbH and Jo-Anne Chan at Burnet Institute, Melbourne explain why the risk of incomplete inactivation or reversion to virulence cause tragic adverse effects in individual cases.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/11/Virus-like-particles_-Versatile-platforms.pdf” width=”100%” height=”900px” style=”border:0;”]

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC